Rui (nmn) Zhu
CIK: 0002153958
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ADRX
ADARx Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Zhu Rui (NMN)
Zhu Rui (NMN) (SEC CIK 0002153958) files insider reports with the SEC as Chief Technology Officer of ADARx Pharmaceuticals, Inc. (ADRX).
Signal8 holds 2 ownership filings by Zhu Rui (NMN) (1 Form 3, 1 Form 4), filed between Sep 24, 2026 and Sep 28, 2026. Those filings report 1 transaction, the latest on Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Zhu Rui (NMN)'s filings is in SAN DIEGO, CA.
Recent filings by Zhu Rui (NMN)
- Sep 24, 2026: Grant or award of ADRX derivative securities (Form 4, code A).
Other insiders filing for ADARx Pharmaceuticals, Inc. (ADRX)
- SR ONE CAPITAL MANAGEMENT, LLC, 10% Owner
- George Simeon, Director
- LAV Biosciences Fund V, L.P., 10% Owner
- MacLeod Alan Robert, Chief Scientific Officer
- Fisk Ryan, CFO and CBO
- Li Zhen, President and CEO